Insulin Receptor Binding: From venom peptides to a potential diabetes treatment

Cone snails have evolved a variety of insulin-like molecules that may help with the development of better treatments for diabetes.
  1. Jiří Jiráček  Is a corresponding author
  2. Lenka Žáková  Is a corresponding author
  1. Czech Academy of Sciences, Czech Republic

The hormone insulin is produced by the pancreas and is important for regulating the sugar levels in the blood. Defects in the production or function of insulin can lead to type 1 or type 2 diabetes, which affect millions of people worldwide. The lives of many of type 1 diabetics are dependent on daily insulin injections, which is also necessary for many type 2 diabetic patients (Zaykov et al., 2016).

The key to effective insulin treatment is fast-acting drugs that can quickly deliver insulin to the target cells and mimic the way that the pancreas can regulate blood sugar levels. Natural insulin is first transported to the liver, where it inhibits the synthesis of glucose, and it only reaches the peripheral tissues later, where it eventually regulates the amount of glucose entering the cells.

However, insulin injections deliver the hormone directly to the periphery, which delays the inhibition of liver glucose production and causes fluctuations of blood sugar levels (Herring et al., 2014). Moreover, at high concentrations, insulin can form aggregates that take time to dissolve and consequently contribute to delaying its action after injection (Figure 1, upper panel; Baker et al., 1988). Developing faster treatments that are not prone to aggregation is a top priority, and although several fast-acting insulins are in clinical use, they still have not reached the same pharmacodynamics as natural insulin secreted by the pancreas (Herring and Russell-Jones, 2018; Zaykov et al., 2016).

Insulin receptor binding in humans and cone snails.

Upper panel: Insulin is secreted by the pancreas in the form of hexamer aggregates with ions (Zn2+) at their center: these aggregates divide to form dimers, which then split to form monomers. Each monomer consists of an A chain (red) and a B chain (gray) with a C-terminal B23-B30 strand. An insulin monomer binds to the L1 domain of an insulin receptor, with the C-terminus of the B chain partially detaching from the central core of the monomer to avoid a clash with the CT peptide (blue) of the receptor. A phenylalanine amino acid residue at the position B24 of insulin (PheB24, black) is crucial for insulin binding. Lower panel: Fish-hunting cone snails secrete insulin-like molecules that do not form aggregates. These molecules induce low blood sugar levels in fish, which stops them escaping. Although cone snail insulin lacks both the C-terminal of the B-chain (gray) and PheB24, it can still bind to fish insulin receptors because it contains two tyrosine amino acid residues (TyrB16 and TyrB20, black) that mimic the missing interactions. The A-chain is shown in beige.

Previous studies were able to identify the structure of the complex that insulin forms with its receptor, and the basics of how insulin binds to the receptor (De Meyts, 2015; Menting et al., 2013; Menting et al., 2014; Scapin et al., 2018; Weis et al., 2018). Now, in eLife, Helena Safavi-Hemami of the University of Utah School of Medicine and colleagues – including Peter Ahorukomeye and Maria Disotuar as joint first authors – report how cone snails could help progress our understanding of this process (Ahorukomeye et al., 2019).

Cone snails have evolved sophisticated strategies for hunting fish. They produce venomous, insulin-like molecules, which they release into the water to paralyze their victim (Figure 1, lower panel). The insulin-like molecules induce low blood sugar levels in their prey, which makes them unable to escape. It has previously been shown that the insulin-like peptide of a cone snail species does not form aggregates (Menting et al., 2016). Therefore, the researchers – who are based at institutes in the United States and Australia – wanted to find out if other cone snails also produced similar substances.

Ahorukomeye et al. discovered that although the species they analyzed made a range of different versions of these insulin-like peptides, none of the molecules could form aggregates. Moreover, the peptides were able to bind to human insulin receptors, and they were also effective in fish and mouse models of the disease, where they reversed high blood sugar levels. Structural and molecular analyses further revealed that the insulin-like peptides of the snails bind in an unusual way to the insulin receptor.

Previous research has shown that a region of insulin that is involved in the cluster formation, the C-terminus of the B chain, is also crucial for binding to the insulin receptor (Figure 1, upper panel; Baker et al., 1988; Menting et al., 2014). However, attempts to remove the B chain to avoid cluster formation have so far compromised the function of insulin.

Ahorukomeye et al. discovered that although the insulin-like peptides produced by the snails lacked the C-terminal part of the B chain, they could still effectively interact with the human insulin receptor. This might be because some their peptides contained hydrophobic amino acid residues that mimic important receptor-binding regions (e.g., phenylalanine at the position B24 of insulin) that had been lost with the missing C-terminal segment (Figure 1, lower panel). Moreover, these regions were very similar among the cone snail species studied. Taken together, these findings indicate that the C-terminus of the B chain is not necessary for insulin binding to the receptor. Future research may build on these results to design potent, fast-acting insulin agonists that are less likely to form aggregates.

The study of Ahorukomeye et al. highlights the beauty of evolution and the adaptability of organisms. We can learn important lessons from Nature as we seek to develop more patient-friendly insulin receptor agonists for the treatment of diabetes.

References

Article and author information

Author details

  1. Jiří Jiráček

    Jiří Jiráček is in the Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Praha, Czech Republic

    For correspondence
    jiracek@uochb.cas.cz
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3848-2773
  2. Lenka Žáková

    Lenka Žáková is in the Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Praha, Czech Republic

    For correspondence
    zakova@uochb.cas.cz
    Competing interests
    No competing interests declared

Publication history

  1. Version of Record published: February 12, 2019 (version 1)

Copyright

© 2019, Jiráček and Žáková

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,098
    Page views
  • 203
    Downloads
  • 3
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jiří Jiráček
  2. Lenka Žáková
(2019)
Insulin Receptor Binding: From venom peptides to a potential diabetes treatment
eLife 8:e44829.
https://doi.org/10.7554/eLife.44829

Further reading

  1. Fast-acting insulin found in certain sea snails could help us to design better diabetes treatments.

    1. Biochemistry and Chemical Biology
    2. Chromosomes and Gene Expression
    Ryo Fujisawa et al.
    Research Article Updated

    The p97/Cdc48 ATPase and its ubiquitin receptors Ufd1-Npl4 are essential to unfold ubiquitylated proteins in many areas of eukaryotic cell biology. In yeast, Cdc48-Ufd1-Npl4 is controlled by a quality control mechanism, whereby substrates must be conjugated to at least five ubiquitins. Here, we show that mammalian p97-UFD1-NPL4 is governed by a complex interplay between additional p97 cofactors and the number of conjugated ubiquitins. Using reconstituted assays for the disassembly of ubiquitylated CMG (Cdc45-MCM-GINS) helicase by human p97-UFD1-NPL4, we show that the unfoldase has a high ubiquitin threshold for substrate unfolding, which can be reduced by the UBX proteins UBXN7, FAF1, or FAF2. Our data indicate that the UBX proteins function by binding to p97-UFD1-NPL4 and stabilising productive interactions between UFD1-NPL4 and K48-linked chains of at least five ubiquitins. Stimulation by UBXN7 is dependent upon known ubiquitin-binding motifs, whereas FAF1 and FAF2 use a previously uncharacterised coiled-coil domain to reduce the ubiquitin threshold of p97-UFD1-NPL4. We show that deleting the Ubnx7 and Faf1 genes impairs CMG disassembly during S-phase and mitosis and sensitises cells to reduced ubiquitin ligase activity. These findings indicate that multiple UBX proteins are important for the efficient unfolding of ubiquitylated proteins by p97-UFD1-NPL4 in mammalian cells.